1 Ocak 2014 Dergi makalesi Açık Erişim

Tasyurek, Mukerrem Hale; Altunbas, Hasan Ali; Canatan, Halit; Griffith, Thomas S.; Sanlioglu, Salih

JSON-LD (schema.org)

{
  "@context": "https://schema.org/", 
  "@id": 62575, 
  "@type": "ScholarlyArticle", 
  "creator": [
    {
      "@type": "Person", 
      "name": "Tasyurek, Mukerrem Hale"
    }, 
    {
      "@type": "Person", 
      "name": "Altunbas, Hasan Ali"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Erciyes Univ, Fac Med, Dept Med Biol, Genome & Stem Cell Res Ctr, TR-38039 Kayseri, Turkey", 
      "name": "Canatan, Halit"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Univ Minnesota, Dept Urol, Minneapolis, MN 55455 USA", 
      "name": "Griffith, Thomas S."
    }, 
    {
      "@type": "Person", 
      "name": "Sanlioglu, Salih"
    }
  ], 
  "datePublished": "2014-01-01", 
  "description": "Glucagon-like peptide (GLP)-1 is an incretin hormone with several antidiabetic functions including stimulation of glucose-dependent insulin secretion, increase in insulin gene expression and beta-cell survival. Despite the initial technical difficulties and profound inefficiency of direct gene transfer into the pancreas that seriously restricted in vivo gene transfer experiments with GLP-1, recent exploitation of various routes of gene delivery and alternative means of gene transfer has permitted the detailed assessment of the therapeutic efficacy of GLP-1 in animal models of type 2 diabetes (T2DM). As a result, many clinical benefits of GLP-1 peptide/analogues observed in clinical trials involving induction of glucose tolerance, reduction of hyperglycaemia, suppression of appetite and food intake linked to weight loss have been replicated in animal models using gene therapy. Furthermore, GLP-1-centered gene therapy not only improved insulin sensitivity, but also reduced abdominal and/or hepatic fat associated with obesity-induced T2DM with drastic alterations in adipokine profiles in treated subjects. Thus, a comprehensive assessment of recent GLP-1-mediated gene therapy approaches with detailed analysis of current hurdles and resolutions, is discussed.", 
  "headline": "GLP-1-mediated gene therapy approaches for diabetes treatment", 
  "identifier": 62575, 
  "image": "https://aperta.ulakbim.gov.tr/static/img/logo/aperta_logo_with_icon.svg", 
  "license": "http://www.opendefinition.org/licenses/cc-by", 
  "name": "GLP-1-mediated gene therapy approaches for diabetes treatment", 
  "url": "https://aperta.ulakbim.gov.tr/record/62575"
}